Alzheimer's Association
banner
alzassociation.bsky.social
Alzheimer's Association
@alzassociation.bsky.social
The Alzheimer’s Association is the leading voluntary health organization in Alzheimer's care, support and research. #ENDALZ

alz.org
We are deeply grateful to everyone who joined us for #GivingTuesday! 💜 Together, we met our 3X Match goal — tripling the impact for families facing Alzheimer’s and accelerating critical research.

Your generosity makes a real difference. Thank you for standing with us in the fight to #ENDALZ.
December 4, 2025 at 12:05 AM
#GivingTuesday Alert: Every donation, up to $750,000, can be matched 3X — but only until MIDNIGHT TONIGHT. ⏰ bit.ly/3Y1wj50
December 3, 2025 at 2:02 AM
With the generosity of supporters like you, we can make a difference. Every dollar raised allows us to provide 24/7 support while accelerating critical research. Donate now and you can have 3X the impact. 💜 bit.ly/3Y1wj50
December 2, 2025 at 9:09 PM
Reposted by Alzheimer's Association
This #GivingTuesday, bring help and hope to families affected by Alzheimer’s. Donate before our #GivingTuesday 3X Match ends at midnight to have your impact go three times as far! 🤲 bit.ly/3Y1wj50
December 2, 2025 at 2:05 PM
This #GivingTuesday, bring help and hope to families affected by Alzheimer’s. Donate before our #GivingTuesday 3X Match ends at midnight to have your impact go three times as far! 🤲 bit.ly/3Y1wj50
December 2, 2025 at 2:05 PM
Tomorrow is #GivingTuesday, and YOU can make three times the difference! 💜

Each gift you make during our #GivingTuesday 3X Match will triple in impact — helping us protect progress, provide 24/7 care and support and accelerate research. bit.ly/3Y1wj50 #ENDALZ
December 1, 2025 at 6:29 PM
#GivingTuesday is NEXT WEEK, but you don’t have to wait to make a gift that can go 3X as far in the fight to #ENDALZ. 🎁

TRIPLE your impact and bring help and hope to the over 7 million Americans living with Alzheimer’s disease and their families. 💜 alz.org/GiveGT
November 25, 2025 at 7:08 PM
The evoke & evoke+ clinical trials testing an oral semaglutide pill to treat early Alzheimer’s did not demonstrate a statistically significant reduction in disease progression. 

While we’re disappointed in the results, these studies provide valuable insights to guide future research. bit.ly/3M0OTaH
Alzheimer’s Association Statement on Oral Semaglutide Phase 3 Topline Data Release
Clinical trials testing an oral semaglutide pill for the treatment of early Alzheimer’s disease did not meet their primary endpoints.
bit.ly
November 24, 2025 at 5:36 PM
Community health workers: Don't miss our Mickal Lewis, MPH, CHW, on @asthonews.bsky.social's free, upcoming webinar discussing how you can address brain health and dementia in your communities. ⬇️
Join ASTHO & the BOLD Public Health Centers of Excellence on Dec. 2 for a webinar on how community health workers promote brain health & address dementias.

Hear insights from ASTHO, @alzassociation.bsky.social, @nyu.edu, & more.

🔗 Register: discover.astho.org/3K1cBmB.
November 18, 2025 at 5:54 PM
Abstract submissions for #AAIC26 are open! Share your landmark findings and shape the future of Alzheimer's disease and dementia research by presenting at the Alzheimer's Association International Conference 2026. Submit by Jan. 12, 2026: alz.org/AAIC
November 17, 2025 at 6:15 PM
We are excited to announce the launch of our Brain Health Habit Builder! 🧠 This free tool helps you check your current habits and create a plan to support your brain health that is backed by research and personalized just for you. Make a plan for a healthy brain today at alz.org/habitbuilder.
November 17, 2025 at 3:04 PM
During #NativeAmericanHeritageMonth, we’re celebrating American Indian and Alaska Natives and their important work to raise Alzheimer’s awareness & better health within their communities, moving us closer to a world without Alzheimer's and all other dementia. #ENDALZ
November 6, 2025 at 2:41 PM
Did you know that engaging in regular exercise can help reduce stress while benefiting your brain health? Get moving and learn more healthy habits for your brain at alz.org/healthyhabits. #NationalStressAwarenessDay
November 5, 2025 at 5:32 PM
🗳️ Help choose the 2026 Supporter Card design!

Make a gift, then vote for your favorite of the 3 finalists here ➡️ bit.ly/4qOWLMD

You’ll receive the winning card design as a sign of your support in the fight against Alzheimer’s. 💜
November 4, 2025 at 3:58 PM
Today marks the start of #NationalFamilyCaregiversMonth — a time to honor the incredible strength, compassion and commitment of those caring for loved ones with Alzheimer’s and other dementia. 💜

Share a tribute to a caregiver in your life at alz.org/honor. #ENDALZ
November 1, 2025 at 12:12 PM
🗒️💜 Note to self as a busy holiday season nears: check in with loved ones, stay informed, and make an impact in the fight against Alzheimer's.

Double your impact with our Grateful Giving 2X Match—happening NOW! ➡️ bit.ly/47GTU0x
October 28, 2025 at 2:43 PM
Reposted by Alzheimer's Association
What can you do to reduce your risk of developing Alzheimer's? And where are we with early detection & treatment? Dr. Heather Snyder of the #AlzheimersAssociation is here w/ news of exciting breakthroughs in the fight against a disease that afflicts 1 in 9 Americans. open.spotify.com/episode/1plT...
Exciting, New Developments in the Fight Against Alzheimer's
open.spotify.com
October 20, 2025 at 6:04 PM
There’s still time to be part of what’s next in neuroscience! Abstract submissions for AAIC Neuroscience Next (Feb. 23-26) are open now until Oct. 22 for students and early career investigators. Learn more: alz.org/NeuroscienceNext. #AAICNeuro
October 20, 2025 at 10:30 PM
Could semaglutide, a GLP-1 drug sold under the brand names Ozempic, Wegovy and Rybelsus, hold promise for early Alzheimer’s? 🔬 Two clinical trials are underway to determine whether the medication can slow the progression of the disease. Learn more: bit.ly/47oCDci.
GLP-1s and Alzheimer’s: What You Need to Know
GLP-1 drugs like semaglutide, known for diabetes and weight loss, are being studied for Alzheimer’s disease. Trial results could reshape future treatment and care.
bit.ly
October 15, 2025 at 9:34 PM
The FDA has cleared the first blood test for Alzheimer’s for use in primary care settings to rule out the presence of amyloid.

“This is another important step toward expanding access to Alzheimer’s diagnostic tools." -Joanne Pike, Association president & CEO

Read our full statement: bit.ly/4oh3Tiu
Alzheimer’s Association Welcomes FDA Clearance of First Blood Test for Use in Primary Care to Rule Out Alzheimer’s-Related Amyloid Pathology
Developed by Roche, this is the first blood test for use in primary care to rule out Alzheimer's-related amyloid pathology.
www.alz.org
October 13, 2025 at 9:14 PM
Registration is open for AAIC Neuroscience Next, Feb. 23-26. This no-cost, global hybrid event is a great opportunity to collaborate and connect both in person and virtually around the globe! Learn more: alz.org/NeuroscienceNext. #AAICNeuro #ALZSky #NeuroSky
October 9, 2025 at 5:36 PM
Autumn changes are in the air. But one thing that never changes is our commitment to the fight against Alzheimer’s. Double your impact on our vital work with our Autumn 2X Match Challenge. 👇

www.alz.org?form=FUNQMTX...
October 7, 2025 at 6:30 PM
📊 New data from the TRAILBLAZER-ALZ 2 long-term extension study show donanemab provided increasing benefits over 3 years—especially when treatment began in the earlier stages of Alzheimer’s, reinforcing that early diagnosis and treatment matter. Read more via Medscape: bit.ly/472CoU9
Alzheimer’s Med Continues to Deliver Benefit at 3 Years
Longer-term data show that donanemab’s cognitive benefits continue to grow over time, and earlier initiation reduces the risk for progression, with no new safety signals.
bit.ly
October 3, 2025 at 1:00 PM
Reposted by Alzheimer's Association
Neuroscience students, postdocs & early career researchers, abstract submissions are open for AAIC Neuroscience Next, Feb. 23-26! Accelerate the future of neuroscience & forge connections across the globe. Learn more: alz.org/NeuroscienceNext. #AAICNeuro #ALZSky #NeuroSky
September 23, 2025 at 11:55 PM
There’s still time to register for the English and Spanish virtual screenings of “Memories of My Grandfather.”

The telenovela centers on the impact of Alzheimer's on a multigenerational Hispanic family in the U.S. Discussion to follow.

Registration links in next post! ⬇️
September 26, 2025 at 4:36 PM